Publicly Available Datasets
English
CIBMTR

数据描述

Publicly Available Datasets

The dataset provides anonymized patient and donor data from hematopoietic stem cell transplants, enabling secondary analysis by researchers. It includes detailed information on diseases, such as leukemias, lymphomas, and other conditions, along with variables related to age, graft source, donor type, and transplant outcomes like overall survival and complications. The dataset also captures data on infusion types, conditioning regimens, and post-transplant events, such as infections and late effects. Its purpose is to support research into transplantation efficacy, safety, and long-term health impacts while safeguarding participant privacy.

cibmtr.org
IP: 104.43.165.136
访问数据源
加载中...

相关论文

8

Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study

Doris K. HansenDanai DimaHira MianJakob DevosRuta Brazauskas30
Blood Cancer Journal
2026
2026/4/14
0
Ciltacabtagene autoleucel (cilta-cel), an anti-B-cell maturation antigen (BCMA) chimeric antigen receptor T-cell (CAR-T) therapy, was approved in 2022 for heavily pretreated relapsed/refractory multiple myeloma (RRMM). This study evaluates the safety and efficacy of cilta-cel in RRMM patients report...
Cancer immunotherapyCancer therapy
10.1038/S41408-026-01496-W
ISSN:2044-5385

Response kinetics and depth of response after idecabtagene vicleucel in relapsed/refractory multiple myeloma

Utkarsh GoelCatalin DragomirescuRoy ChedidDiana BasaliLouis Williams10
Blood Cancer Journal
2026
2026/7/16
Vol.16 No.1 p.1160
Cancer immunotherapyMyeloma
10.1038/S41408-026-01582-Z
ISSN:2044-5385

Incidence of bacterial blood stream infections in patients with acute GVHD

Whitney WallisAlison M. GulbisTao WangCatherine J. LeeAkshay Sharma17
Bone Marrow Transplantation
2024
2024/10/18
00 p.1-6
Bacterial bloodstream infections (BSI) can be a substantial contributor to complications of GVHD treatment. The aim of this study was to determine the risk for BSI from neutrophil engraftment through day 100 post transplant in patients with acute GVHD (AGVHD) based on organ involvement and severity....
Infectious diseasesRisk factors
10.1038/S41409-024-02426-9
ISSN:0268-3369

Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age

Rohtesh S. MehtaChristopher G. KanakryMariam NawasAleksandr LazaryanJennifer A. Kanakry12
Leukemia
2026
2026/4/15
00 p.1-9
In allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide (PTCy), clinicians frequently face a critical choice between a readily available, often younger, haploidentical and a fully matched unrelated donor (MUD). The platform-specific influence of donor age on survival i...
LeukaemiaMedical research
10.1038/S41375-026-02903-8
ISSN:0887-6924

Impact of body mass index on outcomes following allogeneic hematopoietic stem cell transplantation

Moazzam ShahzadAleenah MohsinIbrahim KhameesAqeeb Ur RehmanMuhammad Kashif Amin12
Bone Marrow Transplantation
2025
2025/7/17
00 p.1-4
Haematological cancerRisk factorsStem-cell therapies
10.1038/S41409-025-02680-5
ISSN:0268-3369

Challenging a clinical dogma with multimodal machine learning: a retrospective analysis of transplant mismatched donor selection

Rohtesh S. MehtaShannon R. McCurdyFilippo MilanoMariam NawasYosra Aljawai11
Leukemia
2026
2026/2/9
Vol.40 No.3 p.689-693
LeukaemiaMedical research
10.1038/S41375-026-02878-6
ISSN:0887-6924

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia

Gege GuiNiveditha RavindraPranay S. HegdeGeorgia AndrewDevdeep Mukherjee23
Bone Marrow Transplantation
2024
2024/11/6
00 p.1-7
Measurable residual disease (MRD) in adults with acute myeloid leukemia (AML) in complete remission is an important prognostic marker, but detection methodology requires optimization. Persistence of mutated NPM1 or FLT3-ITD in the blood of adult patients with AML in first complete remission (CR1) pr...
Acute myeloid leukaemiaCancer geneticsTranslational research
10.1038/S41409-024-02447-4
ISSN:0268-3369

Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis

Jeremy RamdialPartow KebriaeiRichard E. ChamplinUday PopatKatayoun Rezvani7
Leukemia
2024
2024/5/2
00 p.1-3
DiseasesMedical research
10.1038/S41375-024-02256-0
ISSN:0887-6924